SEARCH

SEARCH BY CITATION

References

  • Befort K., Filliol D., Decaillot F. M., Gaveriaux-Ruff C., Hoehe M. R. and Kieffer B. L. (2001) A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J. Biol. Chem. 0, 31303137.
  • Bergen A. W., Kokoszka J., Peterson R., Long J. C., Virkkunen M., Linnoila M. and Goldman D. (1997) Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry 2, 490494.
  • Bohm S. K., Grady E. F. and Bunnett N. W. (1997) Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 322, 118.
  • Bond C., LaForge K. S., Tian M. et al. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl Acad. Sci. USA 95, 96089613.
  • Burt R. P., Chapple C. R. and Marshall I. (1996) The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens. Br. J. Pharmacol. 117, 224230.
  • Capeyrou R., Riond J., Corbani M., Lepage J. F., Bertin B. and Emorine L. J. (1997) Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain. FEBS Lett. 415, 200205.
  • Chen C. A. and Okayama H. (1988) Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6, 632638.
  • Ferguson S. S., Downey W. E. 3rd, Colapietro A. M., Barak L. S., Menard L. and Caron M. G. (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271, 363366.
  • Goldstein A. and Naidu A. (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36, 265272.
  • Hoehe M. R., Kopke K., Wendel B., Rohde K., Flachmeier C., Kidd K. K., Berrettini W. H. and Church G. M. (2000) Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum. Mol. Genet. 9, 28952908.
  • Johnson P. S., Wang J. B., Wang W. F. and Uhl G. R. (1994) Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover. Neuroreport 5, 507509.
  • Koch T., Schulz S., Schröder H., Wolf R., Raulf E. and Höllt V. (1998) Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273, 1365213657.
  • Koch T., Kroslak T., Averbeck M., Mayer P., Schröder H., Raulf E. and Höllt V. (2000) Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling. Mol. Pharmacol. 58, 328334.
  • Koch T., Schulz S., Pfeiffer M., Klutzny M., Schröder H., Kahl E. and Höllt V. (2001) C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276, 3140831414.
  • Koch T., Brandenburg L. O., Schulz S., Liang Y., Klein J. and Höllt V. (2003) ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced µ-opioid receptor endocytosis. J. Biol. Chem. 278, 99799985.
  • LaForge K. S., Yuferov V. and Kreek M. J. (2000) Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur. J. Pharmacol. 410, 249268.
  • Lefkowitz R. J., Cotecchia S., Kjelsberg M. A., Pitcher J., Koch W. J., Inglese J. and Caron M. G. (1993) Adrenergic receptors: recent insights into their mechanism of activation and desensitization. Adv. Second Messenger Phosphoprotein Res. 28, 19.
  • Li L. Y. and Chang K. J. (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol. 50, 599602.
  • Li T., Liu X., Zhu Z. H., Zhao J., Hu X., Sham P. C. and Collier D. A. (2000) Association analyses of polymorphisms in the µ opioid gene and heroin abuse in Chinese subjects. Addict. Biol. 5, 181186.
  • Lohse M. J. (1993) Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta 1179, 171188.
  • Lotsch J., Skarke C., Grosch S., Darimont J., Schmidt H. and Geisslinger G. (2002a) The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 12, 39.
  • Lotsch J., Zimmermann M., Darimont J., Marx C., Dudziak R., Skarke C. and Geisslinger G. (2002b) Does the A118G polymorphism at the mu-opioid receptor gene protect agianst morphine-6-glucuronide toxicity. Anesthesiology 97, 814819.
  • Mestek A., Hurley J. H., Bye L. S., Campbell A. D., Chen Y., Tian M., Liu J., Schulman H. and Yu L. (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15, 23962406.
  • Neer E. J. (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80, 249257.
  • Schmidt H., Schulz S., Klutzny M., Koch T. H., Händel M. and Höllt V. (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J. Neurochem. 74, 414422.
  • Schulz S. and Höllt V. (1998) Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur. J. Neurosci. 10, 11961201.
  • Smart D., Smith G. and Lambert D. G. (1994) mu-Opioid receptor stimulation of inositol (1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein. J. Neurochem. 62, 10091014.
  • Smart D., Smith G. and Lambert D. G. (1995) Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. Biochem. J. 305, 577581.
  • Smith F. L., Lohmann A. B. and Dewey W. L. (1999) Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br. J. Pharmacol. 128, 220226.
  • Surratt C. K., Johnson P. S., Moriwaki A., Seidleck B. K., Blaschak C. J., Wang J. B. and Uhl G. R. (1994) -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269, 2054820553.
  • Wang J. M., Hishinuma A., Oppenheim J. J. and Matsushima K. (1993) Studies of binding and internalization of human recombinant monocyte chemotactic and activating factor (MCAF) by monocytic cells. Cytokine 5, 264275.
  • Whistler J. L. and Von Zastrow M. (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl Acad. Sci. USA 95, 99149919.
  • Zhang J., Ferguson S. S., Barak L. S., Bodduluri S. R., Laporte S. A., Law P. Y. and Caron M. G. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl Acad. Sci. USA 95, 71577162.